|
Market Closed -
Nasdaq
21:00:00 02/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 14.99 USD | +0.27% |
|
-3.10% | -17.46% |
| 09-20 | Avalo Therapeutics, Inc.(NasdaqCM:AVTX) added to S&P Global BMI Index | CI |
| 08-19 | Avalo Therapeutics Insider Sold Shares Worth $1,450,419, According to a Recent SEC Filing | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AVTX | Delayed | |
CBOE
| AVTX | Real-time | |
|
Boerse Muenchen
| C6K0 | Real-time | |
|
Deutsche Boerse AG
| C6K0 | Delayed | |
|
Börse Stuttgart
| C6K0 | Delayed | |
|
Tradegate
| C6K0 | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 17.76 | 22.87 | 21.57 |
| Spread/Res. | -15.60% | -34.46% | -30.51% |
| Spread/Supp. | +0.27% | +17.66% | +14.43% |
| Support | 14.95 | 12.74 | 13.1 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- AVTX Stock
- Charts Avalo Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
